+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Biosimilar"

Biosimilars Market by Material Type (Silicon, Germanium, Transition Metal Oxides, Gold), Industry (Consumer Electronics, Automotive, Aviation, Energy, Medical Devices), Regional Outlook - Global Forecast up to 2032 - Product Thumbnail Image

Biosimilars Market by Material Type (Silicon, Germanium, Transition Metal Oxides, Gold), Industry (Consumer Electronics, Automotive, Aviation, Energy, Medical Devices), Regional Outlook - Global Forecast up to 2032

  • Report
  • March 2024
  • 118 Pages
  • Global
From
IgG Mediated Autoimmune Diseases Biologic Drugs Market (2024 Edition): Analysis By Antibody Source (Humanized, Fully Human, Chimeric, Other Sources), By Indication, By Region, By Country: Market Insights and Forecast (2019-2029) - Product Thumbnail Image

IgG Mediated Autoimmune Diseases Biologic Drugs Market (2024 Edition): Analysis By Antibody Source (Humanized, Fully Human, Chimeric, Other Sources), By Indication, By Region, By Country: Market Insights and Forecast (2019-2029)

  • Report
  • March 2024
  • 221 Pages
  • Global
From
Global Biopharma Chromatography Systems Market Size, Share, Trend, Forecast, Competitive Analysis, and Growth Opportunity: 2024-2030 - Product Thumbnail Image

Global Biopharma Chromatography Systems Market Size, Share, Trend, Forecast, Competitive Analysis, and Growth Opportunity: 2024-2030

  • Report
  • February 2024
  • 116 Pages
  • Global
From
Biologics Contract Development and Manufacturing Organizations (CDMOs): Global Markets - Product Thumbnail Image

Biologics Contract Development and Manufacturing Organizations (CDMOs): Global Markets

  • Report
  • October 2023
  • 131 Pages
  • Global
From
US Biosimilar industry outlook to 2028 - Product Thumbnail Image

US Biosimilar industry outlook to 2028

  • Report
  • October 2023
  • 85 Pages
  • United States
From
Growth Opportunities in Global Biosimilars Market, Forecast to 2028 - Product Thumbnail Image

Growth Opportunities in Global Biosimilars Market, Forecast to 2028

  • Report
  • September 2023
  • 76 Pages
  • Global
From
Bioprocessing Markets and Forecast, 2023 - Product Thumbnail Image

Bioprocessing Markets and Forecast, 2023

  • Report
  • August 2023
  • 66 Pages
  • Global
Vietnam Biosimilar Market 2024-2030 Outlook Companies, Size, Analysis, Revenue, Industry, Forecast, Value, Trends, Share, COVID-19 Impact & Growth: Market Forecast By Product Types, By Application, By Manufacturing and Competitive Landscape - Product Thumbnail Image

Vietnam Biosimilar Market 2024-2030 Outlook Companies, Size, Analysis, Revenue, Industry, Forecast, Value, Trends, Share, COVID-19 Impact & Growth: Market Forecast By Product Types, By Application, By Manufacturing and Competitive Landscape

  • Report
  • August 2023
  • 63 Pages
  • Vietnam
From
Growth Opportunities in the Biologics Contract Development and Manufacturing Organization Sector - Product Thumbnail Image

Growth Opportunities in the Biologics Contract Development and Manufacturing Organization Sector

  • Report
  • June 2023
  • 65 Pages
  • Global
From
FDA Regulatory Compliance for Drug and Biotech Product - Past, Present and Future (Recorded) - Product Thumbnail Image

FDA Regulatory Compliance for Drug and Biotech Product - Past, Present and Future (Recorded)

  • Training
  • May 2023
  • 2 Days
  • Global
From
Global Markets for Bioengineered Protein Drugs - Product Thumbnail Image

Global Markets for Bioengineered Protein Drugs

  • Report
  • March 2023
  • 185 Pages
  • Global
From
Biologics Development and Manufacturing Testing: Technologies and Global Markets - Product Thumbnail Image

Biologics Development and Manufacturing Testing: Technologies and Global Markets

  • Report
  • February 2023
  • 123 Pages
  • Global
From
Biosimilars World Market - Product Thumbnail Image

Biosimilars World Market

  • Report
  • January 2023
  • 28 Pages
  • Global
From
Oncology Biosimilars Market, By Type Of Cancer, By Drug Class, Region: Global Forecast to 2028. - Product Thumbnail Image

Oncology Biosimilars Market, By Type Of Cancer, By Drug Class, Region: Global Forecast to 2028.

  • Report
  • November 2022
  • 220 Pages
  • Global
From
Bio similar Monoclonal Antibodies Market, By Application, Type, Region: Global Forecast to 2028. - Product Thumbnail Image

Bio similar Monoclonal Antibodies Market, By Application, Type, Region: Global Forecast to 2028.

  • Report
  • November 2022
  • 220 Pages
  • Global
From
Biopharmaceutical Contract Manufacturing Organization (BCMO) Market, 2022 - Product Thumbnail Image

Biopharmaceutical Contract Manufacturing Organization (BCMO) Market, 2022

  • Report
  • August 2022
  • 180 Pages
  • Global
From
Biologics CDMO Market (2022 Edition) - Analysis By Type (Mammalian, Non-Mammalian), Product Type (Biologics, Biosimilars), By Region, By Country: Market Insights and Forecast with Impact of COVID-19 (2021-2026) - Product Thumbnail Image

Biologics CDMO Market (2022 Edition) - Analysis By Type (Mammalian, Non-Mammalian), Product Type (Biologics, Biosimilars), By Region, By Country: Market Insights and Forecast with Impact of COVID-19 (2021-2026)

  • Report
  • January 2022
  • 194 Pages
  • Global
From
Global Markets and Manufacturing Technologies for Protein Drugs 2021-2026 - Product Thumbnail Image

Global Markets and Manufacturing Technologies for Protein Drugs 2021-2026

  • Report
  • August 2021
  • 159 Pages
  • Global
From
Global Biosimilars Market 2020-2025 - Product Thumbnail Image

Global Biosimilars Market 2020-2025

  • Report
  • May 2021
  • 358 Pages
  • Global
From
The Biosimilars Landscape in Japan: 2009-2020 Study - Product Thumbnail Image

The Biosimilars Landscape in Japan: 2009-2020 Study

  • Report
  • January 2020
  • 156 Pages
  • Japan
From
Loading Indicator

The Biosimilar market is a subset of the biotechnology industry that focuses on the development and production of biologic drugs that are similar to existing biologic drugs. Biosimilars are created using a process called recombinant DNA technology, which involves the manipulation of genetic material to create a drug that is similar to an existing biologic drug. Biosimilars are typically used to treat chronic conditions such as cancer, rheumatoid arthritis, and multiple sclerosis. Biosimilars are typically cheaper than their brand-name counterparts, making them an attractive option for patients and healthcare providers. Some companies in the Biosimilar market include Amgen, Biocon, Celltrion, Dr. Reddy's Laboratories, Mylan, Pfizer, Sandoz, and Teva Pharmaceuticals. Show Less Read more